B. O. Bembeeva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
B. O. Bembeeva has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Tatiana V. Priputnevich
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health, 117997 Moscow, Russia
5 shared publications - Elena L. Isaeva
National Medical Research Center of Obstetrics, Gynecology and Perinatology Named After Academician V.I. Kulakov, Ministry of Health of the Russian Federation, 117997 Moscow, Russia
3 shared publications - Vera V. Muravieva
V.I. Kulakov Obstetrics, Gynecology and Perinatology National Medical Research Center, Ministry of Health of the Russian Federation, Moscow
3 shared publications - Viktor Vasilyevich Zubkov
National Medical Research Center of Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov, Ministry of Health of the Russian Federation, Moscow
3 shared publications - Anastasia Nikolaeva
National Medical Research Center of Obstetrics, Gynecology and Perinatology Named After Academician V.I. Kulakov, Ministry of Health of the Russian Federation, 117997 Moscow, Russia
2 shared publications - Ksenya N. Zhigalova
National Medical Research Center of Obstetrics, Gynecology and Perinatology Named After Academician V.I. Kulakov, Ministry of Health of the Russian Federation, 117997 Moscow, Russia
2 shared publications
Latest Publications
- Open Access
- 9 December 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (12) , 1245
The Impact of Antimicrobial Therapy on the Development of Microbiota in Infants
Background. The establishment and diversity of the gut microbiota during early childhood are fundamental for immune regulation and metabolic processes, with factors such as prematurity, delivery method, antibiotic treatment, and breastfeeding significantly impacting microbiome development and potential health outcomes. Objectives/Methods. This comparative study examined the gut microbiota composition in children aged 6–8 and 9–12 months, born via spontaneous labor at ≥38 weeks’ gestation, who either did not receive antibacterial therapy or required beta-lactam antibiotics. The composition of the colonic microbiota was analyzed in these fecal samples using a quantitative real-time PCR (qRT-PCR). Results. Significant differences in microbiota composition were observed between groups. Children treated with antibiotics exhibited a statistically significant reduction in alpha diversity indices (Shannon and Simpson), along with decreased colonization of key functionally important microorganisms, including obligate anaerobic bacteria such as Faecalibacterium prausnitzii, Clostridium leptum, Bacteroides spp., and metabolically active Bifidobacteria (B. bifidum, B. breve, B. longum). Conclusions. These microbiota alterations may adversely affect child health by diminishing microbial balance and functional potential, especially during this critical period of immune and metabolic development. The decline in anti-inflammatory, short-chain fatty acid-producing bacteria elevates the risk for allergic, atopic, dysbiotic, and metabolic conditions. Recognizing these impacts underscores the importance of strategies to supports microbiota restoration after antibiotic use, such as probiotics, prebiotics, and dietary interventions. Further research should focus on microbiota recovery dynamics to facilitate early intervention and optimize pediatric health outcomes. Overall, understanding antibiotic effects on gut microbiota can guide more judicious treatment approaches, reducing long-term health risks.
- 9 December 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (12) , 1245
Open AccessThe Impact of Antimicrobial Therapy on the Development of Microbiota in Infants
Background. The establishment and diversity of the gut microbiota during early childhood are fundamental for immune regulation and metabolic processes, with factors such as prematurity, delivery method, antibiotic treatment, and breastfeeding significantly impacting microbiome development and potential health outcomes. Objectives/Methods. This comparative study examined the gut microbiota composition in children aged 6–8 and 9–12 months, born via spontaneous labor at ≥38 weeks’ gestation, who either did not receive antibacterial therapy or required beta-lactam antibiotics. The composition of the colonic microbiota was analyzed in these fecal samples using a quantitative real-time PCR (qRT-PCR). Results. Significant differences in microbiota composition were observed between groups. Children treated with antibiotics exhibited a statistically significant reduction in alpha diversity indices (Shannon and Simpson), along with decreased colonization of key functionally important microorganisms, including obligate anaerobic bacteria such as Faecalibacterium prausnitzii, Clostridium leptum, Bacteroides spp., and metabolically active Bifidobacteria (B. bifidum, B. breve, B. longum). Conclusions. These microbiota alterations may adversely affect child health by diminishing microbial balance and functional potential, especially during this critical period of immune and metabolic development. The decline in anti-inflammatory, short-chain fatty acid-producing bacteria elevates the risk for allergic, atopic, dysbiotic, and metabolic conditions. Recognizing these impacts underscores the importance of strategies to supports microbiota restoration after antibiotic use, such as probiotics, prebiotics, and dietary interventions. Further research should focus on microbiota recovery dynamics to facilitate early intervention and optimize pediatric health outcomes. Overall, understanding antibiotic effects on gut microbiota can guide more judicious treatment approaches, reducing long-term health risks.
- Open Access
- 13 January 2025
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 23 (6) , 54-60
Optimising Conditions for the Preservation of Extremely Oxygen Sensitive Obligate Anaerobes of the Gut Microbiota as Candidates for Probiotic Strains
Obligate anaerobic difficult culture bacteria, which make up the bulk of the microbiota of the large intestine, are potential candidates for the development of highly effective new generation probiotics, since they are capable of synthesizing a variety of metabolites, including short-chain fatty acids, which have a stimulating effect on both commensal bacteria and host cells. However, for their long-term preservation, it is necessary to carefully select the preservation method and protective components. To evaluate the efficacy of using different cryoprotectants to increase the viability of obligate anaerobic difficult culture bacteria when preserved by lyophilisation and cryopreservation methods. The studies showed that freeze-drying contributed most to the preservation of the viability of Faecalibacterium prausnitzii, Anaerostipes hadrus, Eubacterium hallii, provided that they were used as a stabilizing medium, which included inulin, cysteine and riboflavin, ensuring the preservation of the initial bacterial titer for 30 days. Among the studied bacteria, the effectiveness of cryopreservation was shown for A. hadrus, since it ensured the survival of bacteria at the initial level for 14 days of storage, regardless of the cryopreservative used, but by the 30th day their viability decreased significantly (by 100 times when using liquid as a cryopreservant). nutrient medium 110 with minced meat and carbohydrates with the addition of glycerin, 10 000 with the commercial cryopreservative CRYOINSTANT). The results obtained allow us to recommend lyophilization as the most optimal method for long-term storage of probiotic strains of bacteria using highly effective stabilizers.
- 13 January 2025
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 23 (6) , 54-60
Open AccessOptimising Conditions for the Preservation of Extremely Oxygen Sensitive Obligate Anaerobes of the Gut Microbiota as Candidates for Probiotic Strains
Obligate anaerobic difficult culture bacteria, which make up the bulk of the microbiota of the large intestine, are potential candidates for the development of highly effective new generation probiotics, since they are capable of synthesizing a variety of metabolites, including short-chain fatty acids, which have a stimulating effect on both commensal bacteria and host cells. However, for their long-term preservation, it is necessary to carefully select the preservation method and protective components. To evaluate the efficacy of using different cryoprotectants to increase the viability of obligate anaerobic difficult culture bacteria when preserved by lyophilisation and cryopreservation methods. The studies showed that freeze-drying contributed most to the preservation of the viability of Faecalibacterium prausnitzii, Anaerostipes hadrus, Eubacterium hallii, provided that they were used as a stabilizing medium, which included inulin, cysteine and riboflavin, ensuring the preservation of the initial bacterial titer for 30 days. Among the studied bacteria, the effectiveness of cryopreservation was shown for A. hadrus, since it ensured the survival of bacteria at the initial level for 14 days of storage, regardless of the cryopreservative used, but by the 30th day their viability decreased significantly (by 100 times when using liquid as a cryopreservant). nutrient medium 110 with minced meat and carbohydrates with the addition of glycerin, 10 000 with the commercial cryopreservative CRYOINSTANT). The results obtained allow us to recommend lyophilization as the most optimal method for long-term storage of probiotic strains of bacteria using highly effective stabilizers.
- Open Access
- 7 November 2024
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 23 (5) , 92-98
Effect of COVID-19 on the Gut Microbiota of Pregnant Women (review)
The Novel coronavirus infection (COVID-19) pandemic has shown that pregnant women are at risk for infection and severe COVID- 19. Pregnant women often experience gastrointestinal symptoms both during the peak of the disease and within 90 days after recovery. This review is devoted to the study of the effect of the SARS-CoV-2 virus on the gut microbiota of pregnant women. Since many studies confirm changes in the composition of the gut microbiota in COVID-19, the dependence of the severity of the course of infection on the composition of the gut microbiota, and the persistence of the virus in the gut after recovery. The question remains whether the composition of the intestinal microbiota changes in pregnant women and newborns during COVID-19, and whether it is possible to correct the state of intestinal dysbiosis during COVID-19 with probiotics for the purpose of prevention and treatment of pregnant women and newborns.
- 7 November 2024
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 23 (5) , 92-98
Open AccessEffect of COVID-19 on the Gut Microbiota of Pregnant Women (review)
The Novel coronavirus infection (COVID-19) pandemic has shown that pregnant women are at risk for infection and severe COVID- 19. Pregnant women often experience gastrointestinal symptoms both during the peak of the disease and within 90 days after recovery. This review is devoted to the study of the effect of the SARS-CoV-2 virus on the gut microbiota of pregnant women. Since many studies confirm changes in the composition of the gut microbiota in COVID-19, the dependence of the severity of the course of infection on the composition of the gut microbiota, and the persistence of the virus in the gut after recovery. The question remains whether the composition of the intestinal microbiota changes in pregnant women and newborns during COVID-19, and whether it is possible to correct the state of intestinal dysbiosis during COVID-19 with probiotics for the purpose of prevention and treatment of pregnant women and newborns.
- 1 May 2024
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 177 (1) , 88-92
Analysis of the Antimicrobial Activity of Epigallocatechin-3-Gallate (EGCG)
We studied antimicrobial activity of epigallocatechin-3-gallate (EGCG), a green tea polyphenolic catechin, and its combined use with ceftazidime (CAZ) agai
- 1 May 2024
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 177 (1) , 88-92
Analysis of the Antimicrobial Activity of Epigallocatechin-3-Gallate (EGCG)
We studied antimicrobial activity of epigallocatechin-3-gallate (EGCG), a green tea polyphenolic catechin, and its combined use with ceftazidime (CAZ) agai
- 1 January 2024
- Published by Publishing House RAMS in Bulletin of Experimental Biology and Medicine
- Vol. 177 (1)
Study of the antimicrobial activity of epigallocatechin-3-gallate (EGCG)
- 1 January 2024
- Published by Publishing House RAMS in Bulletin of Experimental Biology and Medicine
- Vol. 177 (1)
Study of the antimicrobial activity of epigallocatechin-3-gallate (EGCG)
- 1 January 2023
- Published by Geotar-Media Publishing Group in Neonatology: News, Opinions, Training
- Vol. 11 (1)
Development of the gut microbiota of term and late preterm newborn infants
Становление микробиоты кишечника доношенных и поздних недоношенных детей, рожденных самопроизвольно и путем операции кесарева сечения
- 1 January 2023
- Published by Geotar-Media Publishing Group in Neonatology: News, Opinions, Training
- Vol. 11 (1)
Development of the gut microbiota of term and late preterm newborn infants
Становление микробиоты кишечника доношенных и поздних недоношенных детей, рожденных самопроизвольно и путем операции кесарева сечения
- 1 January 2023
- Published by Geotar-Media Publishing Group in Neonatology: News, Opinions, Training
- Vol. 11 (1)
Necrotizing enterocolitis in extremely low birth weight infants and associated risk factors: a retrospective analysis
Факторы, ассоциированные с развитием некротизирующего энтероколита у новорожденных с экстремально низкой массой тела при рождении: ретроспективный
- 1 January 2023
- Published by Geotar-Media Publishing Group in Neonatology: News, Opinions, Training
- Vol. 11 (1)
Necrotizing enterocolitis in extremely low birth weight infants and associated risk factors: a retrospective analysis
Факторы, ассоциированные с развитием некротизирующего энтероколита у новорожденных с экстремально низкой массой тела при рождении: ретроспективный